Eli Lilly Stock: 4 Reasons to Buy the Dip After a 17% Drop

Eli Lilly Stock: 4 Reasons To Buy The Dip After A 17% Drop

3 weeks from now

Jan 14, 2025  · Eli Lilly stock is down 17.75% from its highs as of Jan 10, 2025, even after authorizing a 15 billion stock buyback program. Sales of its GLP-1 drug, Mounjaro, surged …

marketbeat.com

Should You Buy The Dip In Eli Lilly Stock Right Now?

3 weeks from now

Jan 19, 2025  · 2024 was an interesting year for pharmaceutical powerhouse Eli Lilly (LLY 1.67%).At one point, share prices had gained as much as 65% on the year. However, after a …

fool.com

Is Now A Good Time To Buy The Dip In Eli Lilly Stock?

3 weeks from now

Dec 21, 2024  · Since pharmaceutical giant Eli Lilly (LLY-4.21%) reported earnings for the third quarter on Oct. 30, shares have been punished by investors. As of this writing, Lilly's stock …

fool.com

Should You Buy The Dip In Eli Lilly Stock Right Now? - Yahoo Finance

3 weeks from now

Jan 19, 2025  · 2024 was an interesting year for pharmaceutical powerhouse Eli Lilly (NYSE: LLY). At one point, share prices had gained as much as 65% on the year. However, after a less-than …

yahoo.com

Should You Buy The Dip In Eli Lilly Stock Right Now? - MSN

3 weeks from now

All told, Lilly stock still gained 33% in 2024, outperforming the S&P 500 and Nasdaq Composite.Unfortunately, Lilly investors haven't had much to celebrate so far in 2025. On Jan. …

msn.com

Eli Lilly Just Hit A Milestone That Disappointed. Here's Why You …

3 weeks from now

Nov 8, 2024  · During Q3, Eli Lilly brought in $11.4 billion in sales, up 20% from a year prior, and non-GAAP (adjusted) EPS of $1.18, which was $0.29 less than what the average of Wall …

fool.com

Is Now A Good Time To Buy The Dip In Eli Lilly Stock? - Yahoo Finance

3 weeks from now

Nov 21, 2024  · With the price now down 22% from intra-year highs, is now a good time to buy the dip in Eli Lilly stock? ... 2,612.50 +4.40 (+0.17%) My Portfolios. My Portfolios . Sign in to …

yahoo.com

Should You Buy The Dip In Eli Lilly Stock Right Now? - Barchart.com

3 weeks from now

Shares of pharmaceutical stock Eli Lilly are cratering after the company lowered its sales guidance for Q4. ... Nvidia Is Predicted to Become a $10 Trillion Company: Is It Too Late to …

barchart.com

Eli Lilly: 4 Reasons Investors Shouldn’t Miss This Opportunity

3 weeks from now

Jan 15, 2025  · Record sales of its GLP-1 drugs drove Lilly’s stock to a new all-time high of $972.59 in 2024 but have since fallen 17.75% as of Jan 10, 2025. Lilly authorized a $15 billion …

investing.com

Eli Lilly Stock Update: What Investors Should Watch In 2025

3 weeks from now

6 days ago  · On top of that, Eli Lilly has a number of exciting oncology drugs in the works, including STX-478 from Scorpion Therapeutics, for which the company recently paid $2.5 …

marketbeat.com

Eli Lilly Falls More Than 10% In A Month: Buy, Sell Or Hold The Stock?

3 weeks from now

Nov 11, 2024  · Lilly’s stock has risen 42.7% so far this year compared with an increase of 11.6% for the industry. The stock has also outperformed the sector as well as the S&P 500, as seen …

nasdaq.com

Eli Lilly Missed Sales Expectations Again. Should Investors Be …

3 weeks from now

Jan 19, 2025  · Eli Lilly's stock price finished Jan. 16 down 21% from a peak it set last September. The sales trajectory of Mounjaro and Zepbound tapered off in the second half of 2024. An oral …

fool.com

Eli Lilly: Stock Dip Amid Strong Growth Signals - LLY Stock

3 weeks from now

Dec 20, 2024  · Eli Lilly and Company’s stock price fell 1.2% during trading on Thursday, trading as low as $753.33 and closing at $755.37. Analysts remain optimistic, with several rating the …

investingsnacks.com

Should You Buy The Dip In Eli Lilly Stock Right Now? - Sharewise

3 weeks from now

Jan 19, 2025  · All told, Lilly stock still gained 33% in 2024, outperforming the S 500 and Nasdaq Composite. Unfortunately, Lilly investors haven't had much to celebrate so far in 2025. On …

sharewise.com

Eli Lilly: BofA Says Buy The Dip After Shares Slide On Q4 Miss

3 weeks from now

Eli Lilly and Company (NYSE: LLY) shares slid 6.6% to $744.91, after it said it expects Q4 revenue at $13.5 billion- weaker than street expectations of $14.08 billion. The miss was …

investing.com

Going Into Earnings, Is Eli Lilly Stock A Buy, A Sell, Or ... - Morningstar

3 weeks from now

1 day ago  · With its 2-star rating, we believe Eli Lilly’s stock is over-valued compared to our long-term fair value estimate. We are maintaining our Eli Lilly fair value estimate at $580. Mounjaro …

morningstar.com

Why Eli Lilly Is A No-Brainer Stock To Buy On The Dip - MSN

3 weeks from now

What about the lower full-year guidance? Lilly cut its adjusted earnings per share forecast from between $16.10 and $16.60 to between $13.02 and $13.52, a reduction of $3.08 per share at …

msn.com

Eli Lilly Stock's Correction Brings Opportunity (NYSE:LLY)

3 weeks from now

2 days ago  · So I decided to initiate coverage of Eli Lilly with a “Buy” rating. ... there's a reason for LLY stock's dip as of late — the severe miss both on the ... the stock's fair value lies ~17.4% ...

seekingalpha.com

Eli Lilly Cuts Q4 Sales Forecast: ETFs To Buy On The Dip

3 weeks from now

Jan 15, 2025  · The new guidance includes revenues of about $3.5 billion for Mounjaro and $1.9 billion for Zepbound and represents 45% growth from the year-ago quarter. Eli Lilly also cut its …

tradingview.com

Assessing Eli Lilly: Insights From 7 Financial Analysts

3 weeks from now

3 days ago  · Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $1035.29, along with a high estimate of $1190.00 and a low …

nasdaq.com